Blackmores (ASX:BKL) to sell Global Therapeutics for $27 million
Latest Company News - Finance News Network
English - October 27, 2020 00:00 - 54 seconds - 1000 KBBusiness News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Boral (ASX:BLD) to sell 50% interest in USG Boral for $1.43 billion
Next Episode: Novatti Group (ASX:NOV) quarterly update, September 2020
27 Oct 2020 - Blackmores (ASX:BKL) is set to divest Global Therapeutics to McPherson’s.